Last update July 2, 2015
Low Risk
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
Tigecycline in other languages or writings:
Main tradenames from several countries containing Tigecycline in its composition:
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2012 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
On latest update no relevant data related to breastfeeding were found.
Pharmacokinetic data (wide distribution volume, moderately high molecular weight and high protein binding) suggest that excretion into breast milk would not be significant.
Even more, low oral bioavailability makes absorption from ingested breast milk into infant’s blood be nil or scanty. However, in premature infants and neonates in early postpartum, blood levels are likely higher due to increased gut absorption.
Nonetheless, a safer alternative with other known antibiotic is preferred until more information is available.